Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Setnik

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Psychopharmacology|October 21, 2020
Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 StudiesMegan J Shram, Naama Levy-Cooperman, Sian Ratcliffe, et al.
Journal of Clinical Pharmacology|November 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled StudySanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Current Medical Research and Opinion|May 16, 2022
Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidateMegan J Shram, Beatrice Setnik, Lynn Webster, et al.
Pain|May 21, 2015
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatmentRichard L Rauck, Martin E Hale, Almasa Bass, et al.
Journal of Clinical Psychopharmacology|March 16, 2026
A Pilot, Dose-Finding, Pharmacodynamic and Pharmacokinetic Study of Orally Administered Botanical KratomChad J Reissig, Ling Chen, Srikanth C Nallani, et al.
The Journal of Pain|May 9, 2017
Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended ConsiderationsShannon M Smith, Judith K Jones, Nathaniel P Katz, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Psychopharmacology|October 21, 2020
Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 StudiesMegan J Shram, Naama Levy-Cooperman, Sian Ratcliffe, et al.
Journal of Clinical Pharmacology|November 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled StudySanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Current Medical Research and Opinion|May 16, 2022
Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidateMegan J Shram, Beatrice Setnik, Lynn Webster, et al.
Pain|May 21, 2015
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatmentRichard L Rauck, Martin E Hale, Almasa Bass, et al.
Journal of Clinical Psychopharmacology|March 16, 2026
A Pilot, Dose-Finding, Pharmacodynamic and Pharmacokinetic Study of Orally Administered Botanical KratomChad J Reissig, Ling Chen, Srikanth C Nallani, et al.
The Journal of Pain|May 9, 2017
Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended ConsiderationsShannon M Smith, Judith K Jones, Nathaniel P Katz, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 5